Rebates, Employers, and an Important Moment at the Drug Supply Chain Hearing

At a House Energy and Commerce subcommittee hearing last week, the full pharmaceutical drug supply chain testified, including a group that professes to represent employer interests. In one of the more fascinating exchanges, a member of the subcommittee sought to better understand how rebates become part of employer contracts with their pharmacy benefit manager (PBM). […]